Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Binders, fillers, and digestive enzyme degradation compromise data metrics
10.3389/fphar.2021.632295 Summary Keywords gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema Citation Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
The study therefore demonstrates the pro-engiogenic effects of BPC 157 associated with VEGFR2 and VEGFR2-Akt-eNOS signalling
For health decisions, consult a qualified healthcare professional.
US$ 21.69
US$ 28.26
US$ 29.41
US$ 23.84
US$ 20.40
US$ 26.30
